高级检索
当前位置: 首页 > 详情页

Kynurenine derivative 3-HAA is an agonist ligand for transcription factor YY1

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Shanghai Jiao Tong Univ, Sch Med, Tongren Hosp, Chinese Minist Educ,Hongqiao Int Inst Med,Basic M, Shanghai, Peoples R China [2]Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Nucl Med, Shanghai, Peoples R China [3]Shanghai Profleader Biotech Co Ltd, Shanghai, Peoples R China [4]Cent South Univ, Xiangya Sch Pharmaceut Sci, Changsha, Peoples R China [5]Fudan Univ, Sch Life Sci, Shanghai, Peoples R China [6]Chinese Acad Sci, CAS Key Lab Receptor Res, Dept Analyt Chem, Shanghai Inst Mat Med, Shanghai, Peoples R China [7]Xiamen Univ, State Key Lab Cellular Stress Biol, Sch Pharmaceut Sci, Xiamen, Peoples R China [8]Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China
出处:
ISSN:

关键词: 3-Hydroxyanthronic acid (3-HAA) Kynurenine YY1 DUSP6 Hepatocellular carcinoma (HCC) Tryptophan metabolism

摘要:
The 3-hydroxyanthranilic acid (3-HAA), a derivative of kynurenine, was reported to suppress tumor growth. However, the function of 3-HAA largely remains unclear. Here, we report that 3-hydroxyanthranilic acid (3-HAA) is lower in tumor cells, while adding exogenous 3-HAA induces apoptosis in hepatocellular carcinoma by binding YY1. This 3-HAA binding of YY1 leads to phosphorylation of YY1 at the Thr 398 by PKC zeta, concomitantly enhances YY1 chromatin binding activity to increase expression of target genes. These findings demonstrate that 3-HAA is a ligand of YY1, suggesting it is a promising therapeutic candidate for HCC.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 1 区 医学
小类 | 2 区 血液学 2 区 肿瘤学
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 血液学 1 区 肿瘤学
JCR分区:
出版当年[2019]版:
Q1 HEMATOLOGY Q1 ONCOLOGY
最新[2023]版:
Q1 HEMATOLOGY Q1 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Shanghai Jiao Tong Univ, Sch Med, Tongren Hosp, Chinese Minist Educ,Hongqiao Int Inst Med,Basic M, Shanghai, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Shanghai Jiao Tong Univ, Sch Med, Tongren Hosp, Chinese Minist Educ,Hongqiao Int Inst Med,Basic M, Shanghai, Peoples R China [2]Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Nucl Med, Shanghai, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:23425 今日访问量:5 总访问量:1281 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)